HealthShares™ European Drugs ETF (HRJ) is one in a series of HealthShares™ ETFs that are organized Vertically by therapeutic categories in pharmaceuticals, healthcare services, life sciences and biotechnology. HRJ seeks investment results that correspond to the performance, before the Fund’s fees and expenses, of HealthShares™ European Drugs Index, an equity index of publicly traded common stocks and ADRs. The European Drugs Index invests in healthcare, life sciences and/or biotechnology companies that have been identified as European drug companies. Companies included in the European Drugs Index are headquartered in Europe and quoted on at least one European Stock Exchange that are engaged in the research, clinical development, manufacturing and commercialization of pharmaceutical products, small molecule/chemical moieties, biologics (proteins, peptides, oligoneucleotides, and cell/gene therapies) and vaccines, in all therapeutic categories, primarily intended for humans. The companies in this universe are selected using a proprietary methodology developed by XShares Group LLC designed to identify companies in a specific healthcare vertical or sub-sector.
HRJ employs a low-cost passive management investment approach designed to track the performance of the HealthShares™ European Drugs Index. Normal brokerage fees apply. HRJ will generally invest at least 90% of its assets in common stocks of companies in the underlying Index.
HRJ intends to pay out any dividends from its net investment income annually, and plans to distribute any net capital gains annually.
XShares Advisors LLC is the investment advisor for HRJ. Bank of New York acts as custodian and administrator.
| Market data | |
|---|---|
| Market Price (07/02/2007)* | $27.61 |
| Change | $0.79 |
| Volume | 7400 |
| NAV History Premium/Discount Chart | |
| Details | |
|---|---|
| NAV as of 07/02/2007 | $27.4756 |
| NAV Change | $0.6154 |
| Shares Outstanding | 100,200 |
| Total Cash | $2,913.85 |
| Estimated Cash | $2,321.31 |
| Bid as of 07/02/2007 | $27.54 |
| Mid point as of 07/02/2007 | $27.59 |
| Ask as of 07/02/2007 | $27.64 |
| Market Price as of 07/02/2007* | $27.61 |
| Change | $0.79 |
| Premium/Discount*** | 0.4164% |
| Yield | N/A |
| Expense ratio as of 07/02/2007 | 0.95% |
| Inception date | 04/03/2007 |
| Ticker symbol | HRJ |
| IOPV** ticker symbol | HRJ.IV |
* Last Sale.
** Indicative Optimized Portfolio Value.
*** Bid/Ask Midpoint versus NAV.